<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="brief-report">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">J Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">J Infect Dis</journal-id><journal-id journal-id-type="publisher-id">jid</journal-id><journal-title-group><journal-title>The Journal of Infectious Diseases</journal-title></journal-title-group><issn pub-type="ppub">0022-1899</issn><issn pub-type="epub">1537-6613</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38586904</article-id><article-id pub-id-type="pmc">11481323</article-id>
<article-id pub-id-type="doi">10.1093/infdis/jiae172</article-id><article-id pub-id-type="publisher-id">jiae172</article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Report</subject><subj-group subj-group-type="category-toc-heading"><subject>Bacteria</subject></subj-group></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00290</subject></subj-group></article-categories><title-group><article-title>Vaccine-Elicited Antibodies Restrict Glucose Availability to Control <italic toggle="yes">Brucella</italic> Infection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ponzilacqua-Silva</surname><given-names>B&#xE1;rbara</given-names></name><aff>
<institution>Department of Veterinary Pathobiology, College of Veterinary Medicine</institution>
</aff><aff>
<institution>Laboratory for Infectious Disease Research, University of Missouri</institution>, Columbia</aff></contrib><contrib contrib-type="author"><name><surname>Dadelahi</surname><given-names>Alexis S</given-names></name><aff>
<institution>Department of Veterinary Pathobiology, College of Veterinary Medicine</institution>
</aff><aff>
<institution>Laboratory for Infectious Disease Research, University of Missouri</institution>, Columbia</aff></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3616-3800</contrib-id><name><surname>Abushahba</surname><given-names>Mostafa F N</given-names></name><aff>
<institution>Department of Veterinary Pathobiology, College of Veterinary Medicine</institution>
</aff><aff>
<institution>Laboratory for Infectious Disease Research, University of Missouri</institution>, Columbia</aff><aff>
<institution>Department of Zoonoses, Faculty of Veterinary Medicine, Assiut University</institution>, <country country="EG">Egypt</country></aff></contrib><contrib contrib-type="author"><name><surname>Moley</surname><given-names>Charles R</given-names></name><aff>
<institution>Department of Veterinary Pathobiology, College of Veterinary Medicine</institution>
</aff><aff>
<institution>Laboratory for Infectious Disease Research, University of Missouri</institution>, Columbia</aff></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2337-908X</contrib-id><name><surname>Skyberg</surname><given-names>Jerod A</given-names></name><aff>
<institution>Department of Veterinary Pathobiology, College of Veterinary Medicine</institution>
</aff><aff>
<institution>Laboratory for Infectious Disease Research, University of Missouri</institution>, Columbia</aff><xref rid="jiae172-FM1" ref-type="author-notes"/><xref rid="jiae172-cor1" ref-type="corresp"/><!--skybergj@missouri.edu--><xref rid="jiae172-FM10" ref-type="author-notes"/></contrib></contrib-group><author-notes><fn id="jiae172-FM1"><p>Presented in part: Midwest Microbial Pathogenesis Conference, Chicago, Illinois, October 2023.</p></fn><corresp id="jiae172-cor1">Correspondence: Jerod A. Skyberg, PhD, Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, 1500 Bouchelle Ave, Columbia, 65211 (<email>skybergj@missouri.edu</email>).</corresp><fn id="jiae172-FM10" fn-type="COI-statement"><p>
<bold>
<italic toggle="yes">Potential conflicts of interest</italic>.</bold> All authors: No reported conflicts.</p><p>All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.</p></fn></author-notes><pub-date pub-type="collection"><day>15</day><month>10</month><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-04-08"><day>08</day><month>4</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>08</day><month>4</month><year>2024</year></pub-date><volume>230</volume><issue>4</issue><fpage>e818</fpage><lpage>e823</lpage><history><date date-type="received"><day>30</day><month>1</month><year>2024</year></date><date date-type="editorial-decision"><day>28</day><month>3</month><year>2024</year></date><date date-type="accepted"><day>04</day><month>4</month><year>2024</year></date><date date-type="corrected-typeset"><day>26</day><month>4</month><year>2024</year></date></history><permissions><copyright-statement>&#xA9; The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="jiae172.pdf"/><abstract><title>Abstract</title><p>The impact of vaccine-induced immune responses on host metabolite availability has not been well studied. Here we show that prior vaccination alters the metabolic profile of mice challenged with <italic toggle="yes">Brucella melitensis</italic>. In particular, glucose levels were reduced in vaccinated mice in an antibody-dependent manner. We also found the glucose transporter gene <italic toggle="yes">gluP</italic> plays a lesser role in <italic toggle="yes">B melitensis</italic> virulence in vaccinated wild type mice relative to vaccinated mice unable to secrete antibodies. These data indicate that vaccine-elicited antibodies protect the host in part by restricting glucose availability. Moreover, <italic toggle="yes">Brucella</italic> and other pathogens may need to employ different metabolic strategies in vaccinated hosts.</p></abstract><abstract abstract-type="teaser"><p>Prior vaccination alters tissue metabolite levels during <italic toggle="yes">Brucella</italic> infection. In particular, vaccine-elicited antibodies lower tissue glucose levels and diminish the role of a glucose transporter in the virulence of <italic toggle="yes">Brucella</italic>.</p></abstract><kwd-group><kwd>antibody</kwd><kwd><italic toggle="yes">Brucella</italic></kwd><kwd>brucellosis</kwd><kwd>metabolism</kwd><kwd>vaccine</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Institutes of Health</institution><institution-id institution-id-type="DOI">10.13039/100000002</institution-id></institution-wrap>
</funding-source><award-id>R01AI150797</award-id><award-id>R21AI146397</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>University of Missouri Metabolomics Center</institution></institution-wrap>
</funding-source></award-group></funding-group><counts><page-count count="6"/></counts></article-meta></front>
  <body>
    <p>Brucellosis is a worldwide bacterial zoonosis with a broad host range, including wildlife and agriculturally important livestock [<xref rid="jiae172-B1" ref-type="bibr">1</xref>]. The main species recognized as substantial health threats are <italic toggle="yes">Brucella melitensis</italic>, <italic toggle="yes">B abortus</italic>, and <italic toggle="yes">B suis</italic> [<xref rid="jiae172-B2" ref-type="bibr">2</xref>]. Human brucellosis is a severely debilitating disease characterized by persistent waves of fever that typically requires hospitalization [<xref rid="jiae172-B1" ref-type="bibr">1</xref>]. While live vaccines reduce disease incidence in animals, no vaccine is licensed to prevent human brucellosis [<xref rid="jiae172-B2" ref-type="bibr">2</xref>].</p>
    <p>
<italic toggle="yes">Brucella</italic> is a facultative intracellular organism that metabolizes a range of carbon sources to promote its growth and/or virulence, including hexoses, pentoses, glycerol, lactate, glutamate, malate, and fatty acids [<xref rid="jiae172-B3" ref-type="bibr">3&#x2013;7</xref>]. However, it is unknown how vaccine-induced immune responses affect the metabolic conditions that <italic toggle="yes">Brucella</italic> encounters in the host. Here, we performed global screening of host tissue metabolites in <italic toggle="yes">Brucella-</italic>infected mice with and without prior vaccination. In addition, we investigated the effects of host metabolic changes on the requirements for <italic toggle="yes">Brucella</italic> virulence.</p>
    <sec sec-type="materials|methods" id="jiae172-s0">
      <title>METHODS</title>
      <sec id="jiae172-s0.1">
        <title>Mice</title>
        <p>All animal studies were conducted in compliance with the guidelines of the University of Missouri Animal Care and Use Committee. We utilized 6- to 12-week-old age- and sex-matched animals on a C57BL/6J background. C57BL/6J mice were obtained from Jackson Laboratory, and <italic toggle="yes">sIgM</italic><sup>&#x2013;/&#x2013;</sup><italic toggle="yes">AID</italic><sup>&#x2013;/&#x2013;</sup> mice [<xref rid="jiae172-B8" ref-type="bibr">8</xref>, <xref rid="jiae172-B9" ref-type="bibr">9</xref>] were a gift from Dr Nicole Baumgarth at the University of California, Davis.</p>
      </sec>
      <sec id="jiae172-s0.2">
        <title>Bacterial Strains and Growth Conditions</title>
        <p>
<italic toggle="yes">B melitensis</italic> 16M was obtained from Montana State University and <italic toggle="yes">B abortus</italic> S19 from the University of Wyoming. The <italic toggle="yes">gluP</italic> gene (BMEII1053) was previously replaced in frame in <italic toggle="yes">B melitensis</italic> 16M with a chloramphenicol resistance cassette and complemented [<xref rid="jiae172-B10" ref-type="bibr">10</xref>]. The <italic toggle="yes">aceA</italic> gene (BMEI0409) in <italic toggle="yes">B melitensis</italic> 16M was replaced in frame with a chloramphenicol resistance gene in the same manner as described for <italic toggle="yes">gluP</italic> [<xref rid="jiae172-B10" ref-type="bibr">10</xref>] with primers described in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 1</xref>. <italic toggle="yes">Brucella</italic> strains were grown on <italic toggle="yes">Brucella</italic> agar (Becton Dickinson) at 37 &#xB0;C/5% CO<sub>2</sub>. Colonies were transferred to <italic toggle="yes">Brucella</italic> broth (Becton Dickinson) and grown at 37 &#xB0;C with shaking overnight. <italic toggle="yes">Brucella</italic> concentration was estimated by measuring optical density (OD) at 600 nm, and inoculum was prepared and diluted to the appropriate concentration in sterile phosphate-buffered saline (sPBS). Titer was confirmed by serial dilution of inoculum onto agar.</p>
        <p>For vaccination, mice were injected subcutaneously with 2 &#xD7; 10<sup>5</sup> colony-forming units (CFUs) of <italic toggle="yes">B abortus</italic> S19 or with sPBS. After 4 weeks of vaccination, animals were challenged intraperitoneally with 1 &#xD7; 10<sup>5</sup> CFUs of <italic toggle="yes">B melitensis</italic> 16M. For coinfections, mice were challenged intraperitoneally with an inoculum of 1 &#xD7; 10<sup>5</sup> CFUs containing a 1:1 ratio of <italic toggle="yes">B melitensis</italic> 16M and a chloramphenicol-resistant mutant strain (<italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic> or <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">aceA</italic>).</p>
        <p>For passive transfer studies, blood was collected via intracardial exsanguination of C57BL/6J mice vaccinated 4 weeks prior with S19 or from naive C57BL/6J mice. Serum samples were centrifuged, pooled, filtered, and stored at &#x2212;80 &#xB0;C until transfer. For passive transfer, 200 &#xB5;L of serum from S19-vaccinated or naive mice was administrated intraperitoneally to recipients 1 day before challenge.</p>
      </sec>
      <sec id="jiae172-s0.3">
        <title>Calculation of Bacterial Burdens</title>
        <p>Spleens were homogenized mechanically in sPBS. Serial dilutions were performed in triplicate in sPBS and plated onto agar. Plates were incubated for 3 days at 37 &#xB0;C/5% CO<sub>2</sub>, colonies were counted, and CFUs per tissue were calculated. For vaccination experiments, agar was supplemented with 1 mg/mL of erythritol to exclude S19 growth [<xref rid="jiae172-B8" ref-type="bibr">8</xref>]. For competition experiments, bacterial burdens were determined by plating homogenates on agar with or without 5 &#xB5;g/mL of chloramphenicol. The log<sub>10</sub> competitive index (log<sub>10</sub> CI) was calculated by the ratio of bacteria recovery from tissue relative to the ratio in the inoculum [<xref rid="jiae172-B10" ref-type="bibr">10</xref>].</p>
      </sec>
      <sec id="jiae172-s0.4">
        <title>Metabolite Quantification by Gas Chromatography&#x2013;Mass Spectrometry</title>
        <p>Spleens were weighed, and an approximately 40-mg aliquot was used for gas chromatography&#x2013;mass spectrometry (GC-MS), with the remainder used to enumerate <italic toggle="yes">Brucella</italic> burdens. GC-MS was performed at the University of Missouri Metabolomics Center as previously described [<xref rid="jiae172-B10" ref-type="bibr">10</xref>]. Briefly, metabolites from homogenized spleens were extracted in 80% methanol, derivatized, and polar and non-polar metabolites were measured by GC-MS. Results were analyzed with MetaboAnalyst 5.0 [<xref rid="jiae172-B11" ref-type="bibr">11</xref>] with a fold change cutoff of 1.5 and an adjusted <italic toggle="yes">P</italic> value threshold of .05.</p>
      </sec>
      <sec id="jiae172-s0.5">
        <title>RNA Sequencing</title>
        <p>Spleens were homogenized in Trizol Reagent (Thermo Fisher) and RNA isolated according to the manufacturer's instructions. RNA was further purified with RNeasy columns (Qiagen). Poly(A)-enriched stranded mRNA libraries were generated, which were sequenced on a NovaSeq 6000 (Illumina). RNA sequencing analysis was performed with OneStopRNAseq [<xref rid="jiae172-B8" ref-type="bibr">8</xref>, <xref rid="jiae172-B12" ref-type="bibr">12</xref>]. These data were deposited into the NCBI Gene Expression Omnibus and are accessible through accession GSE254248.</p>
      </sec>
      <sec id="jiae172-s0.6">
        <title>Glucose Quantification in Spleens</title>
        <p>Spleen homogenates were frozen at &#x2212;80 &#xB0;C, thawed, and centrifuged, and glucose levels in supernatants were quantified with the Glucose Assay Kit II (Eton Biosciences) according to the manufacturer's instructions.</p>
      </sec>
      <sec id="jiae172-s0.7">
        <title>Effect of Lyxonate and Glucose on <italic toggle="yes">Brucella</italic> Growth In Vitro</title>
        <p>Overnight cultures of <italic toggle="yes">Brucella</italic> were centrifuged and washed with sPBS 3 times. The OD at 600 nm was measured, and cultures were resuspended at an OD of &#x223C;0.05 in Luria-Bertani broth (Becton Dickinson) with or without 0.4% glucose or 0.4% lyxonate (Carbosynth). Samples were then cultured in a 96-well plate and incubated at 37 &#xB0;C/5% CO<sub>2</sub>, and OD measurements were made 24 and 48 hours later.</p>
      </sec>
      <sec id="jiae172-s0.8">
        <title>Statistical Analysis</title>
        <p>All data are expressed as mean and SD. A Student unpaired <italic toggle="yes">t</italic> test was used to assess differences in means between 2 groups, while analysis of variance, followed by a Tukey test, was used for comparisons among &#x2265;3 groups. Significance was set at <italic toggle="yes">P</italic> &lt; .05</p>
        <p>Simple linear regression was used to model the relationship between 2 continuous variables. All statistical analyses were performed with Prism software (version 10.1.1; GraphPad).</p>
      </sec>
    </sec>
    <sec sec-type="results" id="jiae172-s1">
      <title>RESULTS</title>
      <sec id="jiae172-s1.1">
        <title>Vaccination Prior to Challenge Alters the Metabolic and Transcriptomic Profile of Tissues Infected With <italic toggle="yes">Brucella</italic></title>
        <p>
<italic toggle="yes">B abortus</italic> strain S19 (S19) is a smooth live-attenuated vaccine commonly used to prevent brucellosis in cattle that is cross-protective against <italic toggle="yes">B melitensis</italic> [<xref rid="jiae172-B8" ref-type="bibr">8</xref>]. We vaccinated wild type (WT) C57BL/6J mice with S19 or treated them with phosphate-buffered saline (PBS) as a control 4 weeks prior to challenge with <italic toggle="yes">B melitensis</italic>. After 2 weeks of challenge, spleens were harvested for measuring CFUs, metabolomics, and RNA sequencing (<xref rid="jiae172-F1" ref-type="fig">Figure 1</xref><italic toggle="yes"><xref rid="jiae172-F1" ref-type="fig">A</xref></italic>). S19 vaccination conferred approximately 100-fold protection against <italic toggle="yes">B melitensis</italic> (<xref rid="jiae172-F1" ref-type="fig">Figure 1</xref><italic toggle="yes"><xref rid="jiae172-F1" ref-type="fig">B</xref></italic>). In addition, GC-MS revealed differences in metabolite availability in mice vaccinated prior to challenge (<xref rid="jiae172-F1" ref-type="fig">Figure 1</xref><italic toggle="yes"><xref rid="jiae172-F1" ref-type="fig">C</xref></italic> and <xref rid="jiae172-F1" ref-type="fig">1</xref><italic toggle="yes"><xref rid="jiae172-F1" ref-type="fig">D</xref></italic>). A total of 341 polar or nonpolar metabolites were identified, 206 of which were altered at least 1.5-fold by vaccination (<xref rid="sup1" ref-type="supplementary-material">Supplementary Tables 2 and 3</xref>).</p>
        <fig position="float" id="jiae172-F1" fig-type="figure">
          <label>Figure 1.</label>
          <caption>
            <p>Prior vaccination alters the metabolic and transcriptomic profile of spleens in mice challenged with <italic toggle="yes">Brucella melitensis</italic>. <italic toggle="yes">A</italic>, General experimental design for <xref rid="jiae172-F1" ref-type="fig">Figure 1</xref> (image created with <ext-link xlink:href="http://Biorender.com" ext-link-type="uri">Biorender.com</ext-link>). <italic toggle="yes">B&#x2013;E</italic>, C57BL/6J mice (n = 4 or 5/group) were vaccinated subcutaneously with 2 &#xD7; 10<sup>5</sup> CFUs of S19 or treated with PBS 4 weeks prior to intraperitoneal challenge with 1 &#xD7; 10<sup>5</sup> CFUs of <italic toggle="yes">B melitensis</italic> 16M. Two weeks after challenge, splenic levels of <italic toggle="yes">B melitensis</italic> were determined (<italic toggle="yes">B</italic>), and GC-MS was performed to generate a heat map of polar (<italic toggle="yes">C</italic>) and nonpolar (<italic toggle="yes">D</italic>) metabolites in the spleens of mice that received PBS vs S19. <italic toggle="yes">E</italic>, Relative glucose levels in spleens as determined by GC-MS 2 weeks after challenge. <italic toggle="yes">F</italic> and <italic toggle="yes">G</italic>, Wild type mice (n = 3&#x2013;5/group) were treated with PBS or vaccinated subcutaneously with S19 4 weeks prior to intraperitoneal challenge with <italic toggle="yes">B melitensis</italic> 16M (1 &#xD7; 10<sup>5</sup> CFUs). Two weeks postchallenge, RNA sequencing was performed on RNA isolated from spleens. <italic toggle="yes">F</italic>, Volcano plot demonstrating downregulated (left) and upregulated (right) gene expression between groups. The horizontal dashed lines indicate a false discovery rate of 0.05, and genes outside the vertical dashed lines have a 2-fold absolute change. <italic toggle="yes">G</italic>, Transcripts per million (TPM) of <italic toggle="yes">Pparg</italic> in S19-vaccinated and PBS-treated mice 2 weeks after <italic toggle="yes">B melitensis</italic> infection. Data are representative from 1 experiment and presented as mean (SD). *<italic toggle="yes">P</italic> &lt; .05. **<italic toggle="yes">P</italic> &lt; .01. ****<italic toggle="yes">P</italic> &lt; .0001. <italic toggle="yes">t</italic> test. CFU, colony-forming unit; GC-MS, gas chromatography&#x2013;mass spectrometry; ip, intraperitoneally; PBS, phosphate-buffered saline; sc, subcutaneously.</p>
          </caption>
          <graphic xlink:href="jiae172f1" position="float"/>
        </fig>
        <p>When investigating individual metabolites, we found that lyxonate levels were increased approximately 3-fold while glucose levels were decreased approximately 10-fold in spleens of mice vaccinated prior to challenge (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1A</xref> and <xref rid="jiae172-F1" ref-type="fig">Figure 1</xref><italic toggle="yes"><xref rid="jiae172-F1" ref-type="fig">E</xref></italic>). While lyxonate can serve as a carbon source for <italic toggle="yes">Pseudomonas aeruginosa</italic> [<xref rid="jiae172-B13" ref-type="bibr">13</xref>], we noted that lyxonate modestly inhibited <italic toggle="yes">B melitensis</italic> growth in vitro (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1B and 1C</xref>). <italic toggle="yes">Brucella</italic> employs the glucose transporter <italic toggle="yes">gluP</italic> to promote growth in broth and virulence in vivo [<xref rid="jiae172-B10" ref-type="bibr">10</xref>, <xref rid="jiae172-B14" ref-type="bibr">14</xref>, <xref rid="jiae172-B15" ref-type="bibr">15</xref>]. In vitro, <italic toggle="yes">Brucella</italic> utilizes GluP to replicate in proliferator-activated receptor &#x3B3;, expressing alternatively activated macrophages due to elevated glucose in these cells [<xref rid="jiae172-B14" ref-type="bibr">14</xref>]. Interestingly, RNA sequencing revealed that <italic toggle="yes">Pparg</italic> expression was diminished in the spleens of <italic toggle="yes">Brucella</italic>-infected mice that were vaccinated prior to challenge (<xref rid="jiae172-F1" ref-type="fig">Figure 1</xref><italic toggle="yes"><xref rid="jiae172-F1" ref-type="fig">F</xref></italic> and <xref rid="jiae172-F1" ref-type="fig">1</xref><italic toggle="yes"><xref rid="jiae172-F1" ref-type="fig">G</xref></italic> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Table 4</xref>). Levels of eicosapentaenoic acid, which promotes alternative macrophage activation [<xref rid="jiae172-B16" ref-type="bibr">16</xref>], were also lower in vaccinated mice (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 1D</xref>). Therefore, we became interested in whether vaccination alters host glucose availability to control infection.</p>
      </sec>
      <sec id="jiae172-s100.2">
        <title>Vaccine-Elicited Antibodies Restrict Tissue Glucose Availability and Diminish the Role for <italic toggle="yes">Glup</italic> in <italic toggle="yes">B Melitensis</italic> Virulence</title>
        <p>To determine if glucose restriction plays a role in vaccine-mediated immunity, we treated mice with PBS or vaccinated them with S19 4 weeks prior to challenge with a 1:1 ratio of WT <italic toggle="yes">B melitensis</italic> and a chloramphenicol-resistant mutant lacking <italic toggle="yes">gluP</italic>, <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic>. Two weeks after challenge, we determined the ratio of WT <italic toggle="yes">B melitensis</italic> to <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic> in spleens by a log<sub>10</sub> CI based on relative strain recovery, where 0 indicates that the mutant is not attenuated and 1 indicates that the mutant is attenuated 10-fold [<xref rid="jiae172-B10" ref-type="bibr">10</xref>]. Remarkably, the log<sub>10</sub> CI was &gt;10-fold lower in vaccinated animals as compared with PBS-treated mice, indicating that vaccination diminishes the role for <italic toggle="yes">gluP</italic> in <italic toggle="yes">Brucella</italic> virulence (<xref rid="jiae172-F2" ref-type="fig">Figure 2</xref><italic toggle="yes"><xref rid="jiae172-F2" ref-type="fig">A</xref></italic>). We also found that glucose levels were positively correlated with attenuation of <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic> in animals treated with PBS prior to challenge (<xref rid="jiae172-F2" ref-type="fig">Figure 2</xref><italic toggle="yes"><xref rid="jiae172-F2" ref-type="fig">B</xref></italic>) but not in vaccinated animals (<xref rid="jiae172-F2" ref-type="fig">Figure 2</xref><italic toggle="yes"><xref rid="jiae172-F2" ref-type="fig">C</xref></italic>). Together these data demonstrate that S19 vaccination protects the host in part by restricting tissue glucose availability.</p>
        <fig position="float" id="jiae172-F2" fig-type="figure">
          <label>Figure 2.</label>
          <caption>
            <p>Vaccine-elicited antibodies restrict glucose availability to control <italic toggle="yes">Brucella melitensis</italic> infection. <italic toggle="yes">A&#x2013;B</italic>, C57BL/6J (WT) mice (n = 14/group) were treated with PBS or vaccinated subcutaneously with S19 (2 &#xD7; 10<sup>5</sup> CFUs) 4 weeks prior to challenge with 1 &#xD7; 10<sup>5</sup> CFUs of a 1:1 mix of WT <italic toggle="yes">B melitensis</italic> 16M and <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic>. <italic toggle="yes">A</italic>, Two weeks postinfection, a log<sub>10</sub> competitive index (CI) based on relative strain recovery was calculated. <italic toggle="yes">B</italic> and <italic toggle="yes">C</italic>, Glucose levels in spleens were measured via colorimetric assay and plotted against the log<sub>10</sub> CI to perform linear regressions. WT or <italic toggle="yes">sIgM<sup>&#x2212;/&#x2212;</sup>AID<sup>&#x2212;/&#x2212;</sup></italic> mice (n = 17&#x2013;20/group) were vaccinated subcutaneously with S19 (2 &#xD7; 10<sup>5</sup> CFUs) 4 weeks prior to intraperitoneal challenge with 1 &#xD7; 10<sup>5</sup> CFUs of a 1:1 mix of WT <italic toggle="yes">B melitensis</italic> 16M and <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic>. Two weeks postinfection, a log<sub>10</sub> CI based on relative strain recovery was calculated (<italic toggle="yes">D</italic>), and glucose levels in spleens were measured via colorimetric assay (<italic toggle="yes">E</italic>). <italic toggle="yes">F</italic> and <italic toggle="yes">G</italic>, Sterile filtered serum from WT na&#xEF;ve mice (200 &#xB5;L) or from WT mice vaccinated subcutaneously 4 weeks prior with 2 &#xD7; 10<sup>5</sup> CFUs of S19 was transferred intraperitoneally to naive WT recipients (n = 8 or 9/group) 1 day prior to intraperitoneal challenge with 1 &#xD7; 10<sup>5</sup> CFUs of a 1:1 mix of 16M and <italic toggle="yes">Bm</italic>&#x394;<italic toggle="yes">gluP</italic>. Two weeks postinfection, a log<sub>10</sub> CI was calculated (<italic toggle="yes">F</italic>), and glucose levels in spleens were measured (<italic toggle="yes">G</italic>). Data are combined from 2 or 3 experiments and presented as mean (SD). **<italic toggle="yes">P</italic> &lt; .01. ***<italic toggle="yes">P</italic> &lt; .001. ****<italic toggle="yes">P</italic> &lt; .0001. <italic toggle="yes">t</italic> test. <italic toggle="yes">B</italic> and <italic toggle="yes">C</italic>, <italic toggle="yes">P</italic> values were determined via linear regression. CFU, colony-forming unit; OD, optical density; PBS, phosphate-buffered saline; WT, wild type.</p>
          </caption>
          <graphic xlink:href="jiae172f2" position="float"/>
        </fig>
        <p>Studies with B cell&#x2013;deficient mice have indicated that humoral immunity contributes to protection during secondary infection with <italic toggle="yes">B melitensis</italic> [<xref rid="jiae172-B17" ref-type="bibr">17</xref>]. In addition, by using <italic toggle="yes">sIgM<sup>&#x2212;/&#x2212;</sup>AID<sup>&#x2212;/&#x2212;</sup></italic> mice unable to secrete IgM or class-switched antibodies, we determined that S19-mediated immunity against <italic toggle="yes">B melitensis</italic> requires antibody production [<xref rid="jiae172-B8" ref-type="bibr">8</xref>]. To explore the potential connection between antibody production and glucose restriction, we vaccinated WT and <italic toggle="yes">sIgM<sup>&#x2212;/&#x2212;</sup>AID<sup>&#x2212;/&#x2212;</sup></italic> mice with S19 4 weeks prior to coinfection with WT <italic toggle="yes">B melitensis</italic> and <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic>. Two weeks postchallenge, we noted that the log<sub>10</sub> CI was approximately 10-fold higher in <italic toggle="yes">sIgM<sup>&#x2212;/&#x2212;</sup>AID<sup>&#x2212;/&#x2212;</sup></italic> mice as compared with WT animals (<xref rid="jiae172-F2" ref-type="fig">Figure 2</xref><italic toggle="yes"><xref rid="jiae172-F2" ref-type="fig">D</xref></italic>), indicating that <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic> is more highly attenuated in vaccinated animals unable to produce antibodies relative to vaccinated WT mice. We also found that glucose levels were significantly higher in vaccinated <italic toggle="yes">sIgM<sup>&#x2212;/&#x2212;</sup>AID<sup>&#x2212;/&#x2212;</sup></italic> animals as compared with vaccinated WT mice (<xref rid="jiae172-F2" ref-type="fig">Figure 2</xref><italic toggle="yes"><xref rid="jiae172-F2" ref-type="fig">E</xref></italic>). This effect appears to be specific for vaccination, as relative glucose levels and the attenuation of <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic> did not vary in unvaccinated WT vs <italic toggle="yes">sIgM<sup>&#x2212;/&#x2212;</sup>AID<sup>&#x2212;/&#x2212;</sup></italic> mice (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2A and 2B</xref>).</p>
        <p>To confirm that the observed phenotype was conferred by antibodies and not cell-mediated immunity, we performed passive transfer experiments using serum from naive animals or mice vaccinated with S19. Serum was transferred to WT mice a day before coinfection with WT <italic toggle="yes">B melitensis</italic> and <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP.</italic> S19 serum transfer resulted in significantly lower relative attenuation of <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic> as compared with naive serum (<xref rid="jiae172-F2" ref-type="fig">Figure 2</xref><italic toggle="yes"><xref rid="jiae172-F2" ref-type="fig">F</xref></italic>). Corroborating this result, immune serum transfer reduced splenic glucose levels (<xref rid="jiae172-F2" ref-type="fig">Figure 2</xref><italic toggle="yes"><xref rid="jiae172-F2" ref-type="fig">G</xref></italic>). These data collectively indicate that vaccination reduces relative glucose availability in spleens and diminishes the role of <italic toggle="yes">gluP</italic> in <italic toggle="yes">Brucella</italic> virulence in an antibody-dependent manner.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="jiae172-s2">
      <title>DISCUSSION</title>
      <p>
<italic toggle="yes">Brucella</italic> is highly adaptable inside hosts and can use a variety of carbon sources for growth [<xref rid="jiae172-B5" ref-type="bibr">5</xref>]. Here we investigated how induction of host immune responses by vaccination alters metabolite availability and the metabolic requirements for <italic toggle="yes">Brucella</italic> virulence. We determined that the metabolic and transcriptomic profile of animals vaccinated prior to challenge was distinct from PBS-treated animals (<xref rid="jiae172-F1" ref-type="fig">Figure 1</xref>). Interestingly, by employing <italic toggle="yes">sIgM<sup>&#x2212;/&#x2212;</sup>AID<sup>&#x2212;/&#x2212;</sup></italic> mice unable to secrete antibodies and by passive transfer of immune serum, we show that vaccine-elicited antibodies lower tissue glucose levels and diminish the role for <italic toggle="yes">gluP</italic> in <italic toggle="yes">B melitensis</italic> virulence (<xref rid="jiae172-F2" ref-type="fig">Figure 2</xref>). These findings could be due to altered host cell activation, as antibodies can engage Fc receptors or activate complement, which can trigger host cell glycolysis and therefore restrict glucose availability [<xref rid="jiae172-B18" ref-type="bibr">18</xref>, <xref rid="jiae172-B19" ref-type="bibr">19</xref>]. In these conditions, lower glucose levels would diminish growth of WT <italic toggle="yes">B melitensis</italic> but not <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic>, which matches our results where we found that the ratio of WT <italic toggle="yes">B melitensis</italic> to <italic toggle="yes">B melitensis</italic>&#x394;<italic toggle="yes">gluP</italic> is higher in the absence of vaccine-elicited antibodies (<xref rid="jiae172-F2" ref-type="fig">Figure 2</xref>).</p>
      <p>Restriction of glucose availability by vaccine-elicited antibodies likely causes <italic toggle="yes">Brucella</italic> to rely on carbon sources other than glucose to sustain growth and/or virulence. When glycolytic substrates become scarce, <italic toggle="yes">Mycobacterium tuberculosis</italic> employs isocitrate lyases to &#x3B2;-oxidate fatty acids to provide energy [<xref rid="jiae172-B20" ref-type="bibr">20</xref>]. <italic toggle="yes">B melitensis</italic> does encode an isocitrate lyase called <italic toggle="yes">aceA</italic>. However, <italic toggle="yes">aceA</italic> has been reported to be dispensable for <italic toggle="yes">Brucella</italic> virulence [<xref rid="jiae172-B3" ref-type="bibr">3</xref>, <xref rid="jiae172-B4" ref-type="bibr">4</xref>], and we did not find <italic toggle="yes">aceA</italic> to play a differential role in virulence in vaccinated vs naive hosts (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure 2C</xref>). Therefore, if <italic toggle="yes">B melitensis</italic> does &#x3B2;-oxidate fatty acids to sustain virulence in vaccinated hosts, it likely employs isocitrate lyase&#x2013;independent mechanisms, such as <italic toggle="yes">fadA</italic> and <italic toggle="yes">fadJ</italic>, which are implicated in fatty acid &#x3B2;-oxidation and required for <italic toggle="yes">B melitensis</italic> virulence [<xref rid="jiae172-B7" ref-type="bibr">7</xref>]. Alternatively, in a vaccinated host, <italic toggle="yes">Brucella</italic> could use carbon sources other than sugars or fatty acids, as it known that genes associated with metabolism of lactate, glycerol, and glutamate are required for <italic toggle="yes">Brucella</italic> virulence [<xref rid="jiae172-B5" ref-type="bibr">5</xref>, <xref rid="jiae172-B6" ref-type="bibr">6</xref>, <xref rid="jiae172-B15" ref-type="bibr">15</xref>, <xref rid="jiae172-B21" ref-type="bibr">21</xref>].</p>
      <p>Collectively, our data indicate that vaccine-elicited antibodies reduce glucose availability to protect the host against <italic toggle="yes">Brucella</italic>. In addition, <italic toggle="yes">Brucella</italic> and other pathogens may need to employ different metabolic virulence strategies in vaccinated vs naive hosts.</p>
    </sec>
    <sec sec-type="supplementary-material" id="jiae172-s3">
      <title>Supplementary Data</title>
      <p>
<xref rid="sup1" ref-type="supplementary-material">Supplementary materials</xref> are available at <italic toggle="yes">The Journal of Infectious Diseases</italic> online (<ext-link xlink:href="http://jid.oxfordjournals.org/" ext-link-type="uri">http://jid.oxfordjournals.org/</ext-link>). <xref rid="sup1" ref-type="supplementary-material">Supplementary materials</xref> consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all <xref rid="sup1" ref-type="supplementary-material">supplementary data</xref> are the sole responsibility of the authors. Questions or messages regarding errors should be addressed to the author.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material id="sup1" position="float" content-type="local-data">
        <label>jiae172_Supplementary_Data</label>
        <media xlink:href="jiae172_supplementary_data.zip"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <sec id="jiae172-s4">
      <title>Notes</title>
      <p>
<bold>
<italic toggle="yes">Financial support</italic>
</bold>. This work was supported by the National Institutes of Health (grants R01AI150797 and R21AI146397 to J. A. S.); and funding from the University of Missouri Metabolomics Center.</p>
    </sec>
    <ref-list id="ref1">
      <title>References</title>
      <ref id="jiae172-B1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<collab>European Food Safety Authority and European Centre for Disease Prevention and Control</collab>
</person-group>. <article-title>The European Union one health 2019 zoonoses report</article-title>. <source>EFSA J</source><year>2021</year>; <volume>19</volume>:<fpage>e06406</fpage>.<pub-id pub-id-type="pmid">33680134</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Corbel</surname>
<given-names>MJ</given-names>
</string-name>
</person-group>. <article-title>Brucellosis: an overview</article-title>. <source>Emerg Infect Dis</source><year>1997</year>; <volume>3</volume>:<fpage>213</fpage>&#x2013;<lpage>21</lpage>.<pub-id pub-id-type="pmid">9204307</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B3">
        <label>3</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kohler</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Foulongne</surname><given-names>V</given-names></string-name>, <string-name><surname>Ouahrani-Bettache</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>The analysis of the intramacrophagic virulome of <italic toggle="yes">Brucella suis</italic> deciphers the environment encountered by the pathogen inside the macrophage host cell</article-title>. <source>Proc Natl Acad Sci U S A</source><year>2002</year>; <volume>99</volume>:<fpage>15711</fpage>&#x2013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">12438693</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zuniga-Ripa</surname>
<given-names>A</given-names>
</string-name>, <string-name><surname>Barbier</surname><given-names>T</given-names></string-name>, <string-name><surname>Conde-Alvarez</surname><given-names>R</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>
<italic toggle="yes">Brucella abortus</italic> depends on pyruvate phosphate dikinase and malic enzyme but not on Fbp and GlpX fructose-1,6-bisphosphatases for full virulence in laboratory models</article-title>. <source>J Bacteriol</source><year>2014</year>; <volume>196</volume>:<fpage>3045</fpage>&#x2013;<lpage>57</lpage>.<pub-id pub-id-type="pmid">24936050</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B5">
        <label>5</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Barbier</surname>
<given-names>T</given-names>
</string-name>, <string-name><surname>Zuniga-Ripa</surname><given-names>A</given-names></string-name>, <string-name><surname>Moussa</surname><given-names>S</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>
<italic toggle="yes">Brucella</italic> central carbon metabolism: an update</article-title>. <source>Crit Rev Microbiol</source><year>2018</year>; <volume>44</volume>:<fpage>182</fpage>&#x2013;<lpage>211</lpage>.<pub-id pub-id-type="pmid">28604247</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B6">
        <label>6</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Czyz</surname>
<given-names>DM</given-names>
</string-name>, <string-name><surname>Willett</surname><given-names>JW</given-names></string-name>, <string-name><surname>Crosson</surname><given-names>S</given-names></string-name></person-group>. <article-title><italic toggle="yes">Brucella abortus</italic> induces a Warburg shift in host metabolism that is linked to enhanced intracellular survival of the pathogen</article-title>. <source>J Bacteriol</source><year>2017</year>; <volume>199</volume>:<fpage>e00227-17</fpage>.<pub-id pub-id-type="pmid">28559292</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B7">
        <label>7</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Potemberg</surname>
<given-names>G</given-names>
</string-name>, <string-name><surname>Demars</surname><given-names>A</given-names></string-name>, <string-name><surname>Barbieux</surname><given-names>E</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Genome-wide analysis of <italic toggle="yes">Brucella melitensis</italic> genes required throughout intranasal infection in mice</article-title>. <source>PLoS Pathog</source><year>2022</year>; <volume>18</volume>:<fpage>e1010621</fpage>.<pub-id pub-id-type="pmid">35771771</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B8">
        <label>8</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Abushahba</surname>
<given-names>MFN</given-names>
</string-name>, <string-name><surname>Dadelahi</surname><given-names>AS</given-names></string-name>, <string-name><surname>Ponzilacqua-Silva</surname><given-names>B</given-names></string-name>, <string-name><surname>Moley</surname><given-names>CR</given-names></string-name>, <string-name><surname>Skyberg</surname><given-names>JA</given-names></string-name></person-group>. <article-title>Contrasting roles for IgM and B cell MHCII expression in <italic toggle="yes">Brucella abortus</italic> S19 vaccine-mediated efficacy against <italic toggle="yes">B melitensis</italic> infection</article-title>. <source>mSphere</source><year>2024</year>; <volume>9</volume>:<fpage>e00750-23</fpage>.<pub-id pub-id-type="pmid">38349167</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B9">
        <label>9</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Dadelahi</surname>
<given-names>AS</given-names>
</string-name>, <string-name><surname>Abushahba</surname><given-names>MFN</given-names></string-name>, <string-name><surname>Ponzilacqua-Silva</surname><given-names>B</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Interactions between B cells and T follicular regulatory cells enhance susceptibility to <italic toggle="yes">Brucella</italic> infection independent of the anti-<italic toggle="yes">Brucella</italic> humoral response</article-title>. <source>PLoS Pathog</source><year>2023</year>; <volume>19</volume>:<fpage>e1011672</fpage>.<pub-id pub-id-type="pmid">37721965</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B10">
        <label>10</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lacey</surname>
<given-names>CA</given-names>
</string-name>, <string-name><surname>Ponzilacqua-Silva</surname><given-names>B</given-names></string-name>, <string-name><surname>Chambers</surname><given-names>CA</given-names></string-name>, <string-name><surname>Dadelahi</surname><given-names>AS</given-names></string-name>, <string-name><surname>Skyberg</surname><given-names>JA</given-names></string-name></person-group>. <article-title>MyD88-dependent glucose restriction and itaconate production control <italic toggle="yes">Brucella</italic> infection</article-title>. <source>Infect Immun</source><year>2021</year>; <volume>89</volume>:<fpage>e0015621</fpage>.<pub-id pub-id-type="pmid">34125603</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B11">
        <label>11</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xia</surname>
<given-names>J</given-names>
</string-name>, <string-name><surname>Psychogios</surname><given-names>N</given-names></string-name>, <string-name><surname>Young</surname><given-names>N</given-names></string-name>, <string-name><surname>Wishart</surname><given-names>DS</given-names></string-name></person-group>. <article-title>MetaboAnalyst: a web server for metabolomic data analysis and interpretation</article-title>. <source>Nucleic Acids Res</source><year>2009</year>; <volume>37</volume>:<fpage>W652</fpage>&#x2013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">19429898</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B12">
        <label>12</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname>
<given-names>R</given-names>
</string-name>, <string-name><surname>Hu</surname><given-names>K</given-names></string-name>, <string-name><surname>Liu</surname><given-names>H</given-names></string-name>, <string-name><surname>Green</surname><given-names>MR</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>LJ</given-names></string-name></person-group>. <article-title>OneStopRNAseq: a web application for comprehensive and efficient analyses of RNA-Seq data</article-title>. <source>Genes (Basel)</source><year>2020</year>; <volume>11</volume>:<fpage>1165</fpage>.<pub-id pub-id-type="pmid">33023248</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B13">
        <label>13</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ghasempur</surname>
<given-names>S</given-names>
</string-name>, <string-name><surname>Eswaramoorthy</surname><given-names>S</given-names></string-name>, <string-name><surname>Hillerich</surname><given-names>BS</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Discovery of a novel L-lyxonate degradation pathway in <italic toggle="yes">Pseudomonas aeruginosa</italic> PAO1</article-title>. <source>Biochemistry</source><year>2014</year>; <volume>53</volume>:<fpage>3357</fpage>&#x2013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">24831290</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B14">
        <label>14</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xavier</surname>
<given-names>MN</given-names>
</string-name>, <string-name><surname>Winter</surname><given-names>MG</given-names></string-name>, <string-name><surname>Spees</surname><given-names>AM</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>PPARgamma-mediated increase in glucose availability sustains chronic <italic toggle="yes">Brucella abortus</italic> infection in alternatively activated macrophages</article-title>. <source>Cell Host Microbe</source><year>2013</year>; <volume>14</volume>:<fpage>159</fpage>&#x2013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">23954155</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B15">
        <label>15</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hong</surname>
<given-names>PC</given-names>
</string-name>, <string-name><surname>Tsolis</surname><given-names>RM</given-names></string-name>, <string-name><surname>Ficht</surname><given-names>TA</given-names></string-name></person-group>. <article-title>Identification of genes required for chronic persistence of <italic toggle="yes">Brucella abortus</italic> in mice</article-title>. <source>Infect Immun</source><year>2000</year>; <volume>68</volume>:<fpage>4102</fpage>&#x2013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">10858227</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B16">
        <label>16</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Videla</surname>
<given-names>LA</given-names>
</string-name>, <string-name><surname>Valenzuela</surname><given-names>R</given-names></string-name>, <string-name><surname>Del Campo</surname><given-names>A</given-names></string-name>, <string-name><surname>Zuniga-Hernandez</surname><given-names>J</given-names></string-name></person-group>. <article-title>Omega-3 lipid mediators: modulation of the M1/M2 macrophage phenotype and its protective role in chronic liver diseases</article-title>. <source>Int J Mol Sci</source><year>2023</year>; <volume>24</volume>:<fpage>15528</fpage>.<pub-id pub-id-type="pmid">37958514</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B17">
        <label>17</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Vitry</surname>
<given-names>MA</given-names>
</string-name>, <string-name><surname>Hanot Mambres</surname><given-names>D</given-names></string-name>, <string-name><surname>De Trez</surname><given-names>C</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with <italic toggle="yes">Brucella melitensis</italic></article-title>. <source>J Immunol</source><year>2014</year>; <volume>192</volume>:<fpage>3740</fpage>&#x2013;<lpage>52</lpage>.<pub-id pub-id-type="pmid">24646742</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B18">
        <label>18</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jing</surname>
<given-names>C</given-names>
</string-name>, <string-name><surname>Castro-Dopico</surname><given-names>T</given-names></string-name>, <string-name><surname>Richoz</surname><given-names>N</given-names></string-name></person-group>
<article-title>, et al. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis</article-title>. <source>Proc Natl Acad Sci U S A</source><year>2020</year>; <volume>117</volume>:<fpage>15160</fpage>&#x2013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">32541026</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B19">
        <label>19</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hess</surname>
<given-names>C</given-names>
</string-name>, <string-name><surname>Kemper</surname><given-names>C</given-names></string-name></person-group>. <article-title>Complement-mediated regulation of metabolism and basic cellular processes</article-title>. <source>Immunity</source><year>2016</year>; <volume>45</volume>:<fpage>240</fpage>&#x2013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">27533012</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B20">
        <label>20</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Munoz-Elias</surname>
<given-names>EJ</given-names>
</string-name>, <string-name><surname>McKinney</surname><given-names>JD</given-names></string-name></person-group>. <article-title><italic toggle="yes">Mycobacterium tuberculosis</italic> isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence</article-title>. <source>Nat Med</source><year>2005</year>; <volume>11</volume>:<fpage>638</fpage>&#x2013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">15895072</pub-id>
</mixed-citation>
      </ref>
      <ref id="jiae172-B21">
        <label>21</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lestrate</surname>
<given-names>P</given-names>
</string-name>, <string-name><surname>Dricot</surname><given-names>A</given-names></string-name>, <string-name><surname>Delrue</surname><given-names>RM</given-names></string-name>, <etal>et al</etal></person-group>
<article-title>Attenuated signature-tagged mutagenesis mutants of <italic toggle="yes">Brucella melitensis</italic> identified during the acute phase of infection in mice</article-title>. <source>Infect Immun</source><year>2003</year>; <volume>71</volume>:<fpage>7053</fpage>&#x2013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">14638795</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>